Clearside Biomedical, Inc. Annual Return On Equity in % from 2017 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Clearside Biomedical, Inc. quarterly/annual Return On Equity history and growth rate from 2017 to 2023.
  • Clearside Biomedical, Inc. Return On Equity for the quarter ending September 30, 2024 was 127 %, a 96.2% decline year-over-year.
  • Clearside Biomedical, Inc. annual Return On Equity for 2023 was 419 %.
  • Clearside Biomedical, Inc. annual Return On Equity for 2022 was -153 %, a 9477% decline from 2021.
  • Clearside Biomedical, Inc. annual Return On Equity for 2021 was 1.63 %.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 419 +572 Jan 1, 2023 Dec 31, 2023
2022 -153 -155 -9477% Jan 1, 2022 Dec 31, 2022
2021 1.63 +212 Jan 1, 2021 Dec 31, 2021
2020 -210 +36.2 +14.7% Jan 1, 2020 Dec 31, 2020
2019 -247 -96.2 -64% Jan 1, 2019 Dec 31, 2019
2018 -150 -19.2 -14.6% Jan 1, 2018 Dec 31, 2018
2017 -131 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.